25 Feb Vor Biopharma
Posted at 15:57h
in
Robert Ang, President and CEO
April 21 | 2:45pm | Gaudi 3 Ballroom
Cambridge, MA
(NASDAQ: VOR)
In-Person Presentation
Vor Biopharma is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. Our vision is to cure blood cancers through cell and genome engineering.
